Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking

GLIA

Volumn 64, Issue 1, 2016, Pages 155-174

  Patzig, Julia ^a   Kusch, Kathrin ^a   Fledrich, Robert ^a   Eichel, Maria A ^a   Lüders, Katja A ^a   Möbius, Wiebke ^a,b   Sereda, Michael W ^a,c   Nave, Klaus Armin ^a   Martini, Rudolf ^d   Werner, Hauke B ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB)   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Charcot Marie tooth disease; Dejerine Sottas syndrome; Glia axonal support; Hereditary spastic paraplegia (SPG 2); Myelin; Neurodegeneration; Neuropathy; Oligodendrocyte; Schwann cell

Indexed keywords

MYELIN PROTEIN; MYELIN PROTEIN ZERO; PROTEOLIPID PROTEIN; UNCLASSIFIED DRUG; MAG PROTEIN, MOUSE; MPZ PROTEIN, MOUSE; MYELIN ASSOCIATED GLYCOPROTEIN; PLP1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; MALE; MOTOR PERFORMANCE; MOUSE; MUTANT; MYELINATION; NERVE CONDUCTION; NERVE FIBER; NONHUMAN; PHRENIC NERVE; PRESERVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHWANN CELL; ANIMAL; AXON; BRAIN; C57BL MOUSE; GENETICS; KAPLAN MEIER METHOD; KNOCKOUT MOUSE; METABOLISM; MOTOR ACTIVITY; MYELIN SHEATH; OPTIC NERVE; PATHOLOGY; PHYSIOLOGY; PREMATURE MORTALITY; SCIATIC NERVE;

ANIMALS; AXONS; BRAIN; FEMALE; KAPLAN-MEIER ESTIMATE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORTALITY, PREMATURE; MOTOR ACTIVITY; MYELIN P0 PROTEIN; MYELIN PROTEOLIPID PROTEIN; MYELIN SHEATH; MYELIN-ASSOCIATED GLYCOPROTEIN; NEURAL CONDUCTION; OPTIC NERVE; PHRENIC NERVE; SCIATIC NERVE;

EID: 84954389483     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22922     Document Type: Article

References (131)

1. Aboussouan LS, Lewis RA, Shy ME. 2007. Disorders of pulmonary function, sleep, and the upper airway in Charcot-Marie-Tooth disease. Lung 185:1-7.
2. Anderson TJ, Montague P, Nadon N, Nave KA, Griffiths IR. 1997. Modification of Schwann cell phenotype with Plp transgenes: Evidence that the PLP and DM20 isoproteins are targeted to different cellular domains. J Neurosci Res 50:13-22.
3. Anderson TJ, Schneider A, Barrie JA, Klugmann M, McCulloch MC, Kirkham D, Kyriakides E, Nave KA, Griffiths IR. 1998. Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene. J Comp Neurol 394:506-519.
4. Archelos JJ, Roggenbuck K, Schneider-Schaulies J, Linington C, Toyka KV, Hartung HP. 1993. Production and characterization of monoclonal antibodies to the extracellular domain of P0. J Neurosci Res 35:46-53.
5. Beirowski B, Babetto E, Golden JP, Chen YJ, Yang K, Gross RW, Patti GJ, Milbrandt J. 2014. Metabolic regulator LKB1 is crucial for Schwann cell-mediated axon maintenance. Nat Neurosci 17:1351-1361.
6. Berger P, Niemann A, Suter U. 2006. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease). Glia 54:243-257.
7. Berghoff M, Samsam M, Muller M, Kobsar I, Toyka KV, Kiefer R, Maurer M, Martini R. 2005. Neuroprotective effect of the immune system in a mouse model of severe dysmyelinating hereditary neuropathy: Enhanced axonal degeneration following disruption of the RAG-1 gene. Mol Cell Neurosci 28:118-127.
8. Bosse F, Hasse B, Pippirs U, Greiner-Petter R, Muller HW. 2003. Proteolipid plasmolipin: Localization in polarized cells, regulated expression and lipid raft association in CNS and PNS myelin. J Neurochem 86:508-518.
9. Boucher SE, Cypher MA, Carlock LR, Skoff RP. 2002. Proteolipid protein gene modulates viability and phenotype of neurons. J Neurosci 22:1772-1783.
10. Bradl M, Bauer J, Inomata T, Zielasek J, Nave KA, Toyka K, Lassmann H, Wekerle H. 1999. Transgenic Lewis rats overexpressing the proteolipid protein gene: Myelin degeneration and its effect on T cell-mediated experimental autoimmune encephalomyelitis. Acta Neuropathol 97:595-606.
11. Brosius Lutz A, Barres BA. 2014. Contrasting the glial response to axon injury in the central and peripheral nervous systems. Dev Cell 28:7-17.
12. Carenini S, Maurer M, Werner A, Blazyca H, Toyka KV, Schmid CD, Raivich G, Martini R. 2001. The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0. J Cell Biol 152:301-308.
13. Carenini S, Montag D, Schachner M, Martini R. 1999a. Subtle roles of neural cell adhesion molecule and myelin-associated glycoprotein during Schwann cell spiralling in P0-deficient mice. Glia 27:203-212.
14. Carenini S, Neuberg D, Schachner M, Suter U, Martini R. 1999b. Localization and functional roles of PMP22 in peripheral nerves of P0-deficient mice. Glia 28:256-264.
15. Coleman MP, Freeman MR. 2010. Wallerian degeneration, wld(s), and nmnat. Annu Rev Neurosci 33:245-267.
16. D'Urso D, Brophy PJ, Staugaitis SM, Gillespie CS, Frey AB, Stempak JG, Colman DR. 1990. Protein zero of peripheral nerve myelin: Biosynthesis, membrane insertion, and evidence for homotypic interaction. Neuron 4:449-460.
17. De Jonghe P, Timmerman V, Ceuterick C, Nelis E, De Vriendt E, Lofgren A, Vercruyssen A, Verellen C, Van Maldergem L, Martin JJ, Van Broeckhoven C. 1999. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain 122:281-290.
18. de Monasterio-Schrader P, Jahn O, Tenzer S, Wichert SP, Patzig J, Werner HB. 2012. Systematic approaches to central nervous system myelin. Cell Mol Life Sci 69:2879-2894.
19. de Monasterio-Schrader P, Patzig J, Mobius W, Barrette B, Wagner TL, Kusch K, Edgar JM, Brophy PJ, Werner HB. 2013. Uncoupling of neuroinflammation from axonal degeneration in mice lacking the myelin protein tetraspanin-2. Glia 61:1832-1847.
20. de Waegh SM, Lee VM, Brady ST. 1992. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68:451-463.
21. Dobretsova A, Johnson JW, Jones RC, Edmondson RD, Wight PA. 2008. Proteomic analysis of nuclear factors binding to an intronic enhancer in the myelin proteolipid protein gene. J Neurochem 105:1979-1995.
22. Duncan ID. 2005. The PLP mutants from mouse to man. J Neurol Sci 228:204-205.
23. Edgar JM, Anderson TJ, Dickinson PJ, Barrie JA, McCulloch MC, Nave KA, Griffiths IR. 2002. Survival of, and competition between, oligodendrocytes expressing different alleles of the Plp gene. J Cell Biol 158:719-729.
24. Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler JH, Montague P, Barrie JA, McCulloch MC, Duncan ID, Garbern J, Nave KA, Griffiths IR. 2004. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 166:121-131.
25. Edgar JM, Nave KA. 2009. The role of CNS glia in preserving axon function. Curr Opin Neurobiol 19:498-504.
26. Filbin MT, Walsh FS, Trapp BD, Pizzey JA, Tennekoon GI. 1990. Role of myelin P0 protein as a homophilic adhesion molecule. Nature 344:871-872.
27. Fischer S, Kleinschnitz C, Muller M, Kobsar I, Ip CW, Rollins B, Martini R. 2008. Monocyte chemoattractant protein-1 is a pathogenic component in a model for a hereditary peripheral neuropathy. Mol Cell Neurosci 37:359-366.
28. Frei R, Motzing S, Kinkelin I, Schachner M, Koltzenburg M, Martini R. 1999. Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice. J Neurosci 19:6058-6067.
29. Fruttiger M, Montag D, Schachner M, Martini R. 1995. Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur J Neurosci 7:511-515.
30. Garbern JY. 2007. Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis. Cell Mol Life Sci 64:50-65.
31. Garbern JY, Cambi F, Lewis R, Shy M, Sima A, Kraft G, Vallat JM, Bosch EP, Hodes ME, Dlouhy S, Raskind W, Bird T, Macklin W, Kamholz J. 1999. Peripheral neuropathy caused by proteolipid protein gene mutations. Ann N Y Acad Sci 883:351-365.
32. Garbern JY, Cambi F, Tang XM, Sima AA, Vallat JM, Bosch EP, Lewis R, Shy M, Sohi J, Kraft G, Chen KL, Joshi I, Leonard DG, Johnson W, Raskind W, Dlouhy SR, Pratt V, Hodes ME, Bird T, Kamholz J. 1997. Proteolipid protein is necessary in peripheral as well as central myelin. Neuron 19:205-218.
33. Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, Sistermans EA, van der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR. 2002. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125:551-561.
34. Ghazvini M, Mandemakers W, Jaegle M, Piirsoo M, Driegen S, Koutsourakis M, Smit X, Grosveld F, Meijer D. 2002. A cell type-specific allele of the POU gene Oct-6 reveals Schwann cell autonomous function in nerve development and regeneration. EMBO J 21:4612-4620.
35. Giese KP, Martini R, Lemke G, Soriano P, Schachner M. 1992. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71:565-576.
36. Gomez-Sanchez JA, Carty L, Iruarrizaga-Lejarreta M, Palomo-Irigoyen M, Varela-Rey M, Griffith M, Hantke J, Macias-Camara N, Azkargorta M, Aurrekoetxea I, De Juan VG, Jefferies HB, Aspichueta P, Elortza F, Aransay AM, Martínez-Chantar ML, Baas F, Mato JM, Mirsky R, Woodhoo A, Jessen KR. 2015. Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves. J Cell Biol 210:153-168.
37. Gow A, Wrabetz L. 2009. CHOP and the endoplasmic reticulum stress response in myelinating glia. Curr Opin Neurobiol 19:505-510.
38. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmermann F, McCulloch M, Nadon N, Nave KA. 1998. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610-1613.
39. Groh J, Heinl K, Kohl B, Wessig C, Greeske J, Fischer S, Martini R. 2010. Attenuation of MCP-1/CCL2 expression ameliorates neuropathy in a mouse model for Charcot-Marie-Tooth 1X. Hum Mol Genet 19:3530-3543.
40. Groh J, Klein I, Hollmann C, Wettmarshausen J, Klein D, Martini R. 2015. CSF-1-activated macrophages are target-directed and essential mediators of Schwann cell dedifferentiation and dysfunction in Cx32-deficient mice. Glia 63:977-986.
41. Groh J, Weis J, Zieger H, Stanley ER, Heuer H, Martini R. 2012. Colony-stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot-Marie-Tooth disease type 1X. Brain 135:88-104.
42. Hahn JS, Henry M, Hudgins L, Madan A. 2001. Congenital hypomyelination neuropathy in a newborn infant: Unusual cause of diaphragmatic and vocal cord paralyses. Pediatrics 108:E95.
43. Hammer JA, O'Shannessy DJ, De Leon M, Gould R, Zand D, Daune G, Quarles RH. 1993. Immunoreactivity of PMP-22, P0, and other 19 to 28 kDa glycoproteins in peripheral nerve myelin of mammals and fish with HNK1 and related antibodies. J Neurosci Res 35:546-558.
44. Jaegle M, Mandemakers W, Broos L, Zwart R, Karis A, Visser P, Grosveld F, Meijer D. 1996. The POU factor Oct-6 and Schwann cell differentiation. Science 273:507-510.
45. Jahn O, Tenzer S, Bartsch N, Patzig J, Werner HB. 2013. Myelin proteome analysis: Methods and implications for the myelin cytoskeleton. Neuromethods 79:335-353.
46. Jahn O, Tenzer S, Werner HB. 2009. Myelin proteomics: Molecular anatomy of an insulating sheath. Mol Neurobiol 40:55-72.
47. Jessen KR, Mirsky R, Lloyd AC. 2015. Schwann cells: Development and role in nerve repair. Cold Spring Harb Perspect Biol 7:a020487. doi: 10.1101/cshperspect.a020487. PMID:25957303.
48. Jung M, Sommer I, Schachner M, Nave KA. 1996. Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): Evidence that PLP misfolding underlies dysmyelination in mutant mice. J Neurosci 16:7920-7929.
49. Kagawa T, Ikenaka K, Inoue Y, Kuriyama S, Tsujii T, Nakao J, Nakajima K, Aruga J, Okano H, Mikoshiba K. 1994. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13:427-442.
50. Klein D, Groh J, Weishaupt A, Martini R. 2015a. Endogenous antibodies contribute to macrophage-mediated demyelination in a mouse model for CMT1B. J Neuroinflammation 12:49.
51. Klein D, Patzko A, Schreiber D, van Hauwermeiren A, Baier M, Groh J, West BL, Martini R. 2015b. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice. Brain pii: awv240. [Epub ahead of print]. doi: 10.1093/brain/awv240. PMID:26297559.
52. Klugmann M, Schwab MH, Puhlhofer A, Schneider A, Zimmermann F, Griffiths IR, Nave KA. 1997. Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18:59-70.
53. Kobsar I, Berghoff M, Samsam M, Wessig C, Maurer M, Toyka KV, Martini R. 2003. Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1. Brain 126:804-813.
54. Kuhlbrodt K, Herbarth B, Sock E, Hermans-Borgmeyer I, Wegner M. 1998. Sox10, a novel transcriptional modulator in glial cells. J Neurosci 18:237-250.
55. LeBlanc SE, Jang SW, Ward RM, Wrabetz L, Svaren J. 2006. Direct regulation of myelin protein zero expression by the Egr2 transactivator. J Biol Chem 281:5453-5460.
56. Lemke G, Axel R. 1985. Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell 40:501-508.
57. Li C, Tropak MB, Gerlai R, Clapoff S, Abramow-Newerly W, Trapp B, Peterson A, Roder J. 1994. Myelination in the absence of myelin-associated glycoprotein. Nature 369:747-750.
58. Li J, Bai Y, Ianakova E, Grandis M, Uchwat F, Trostinskaia A, Krajewski KM, Garbern J, Kupsky WJ, Shy ME. 2006. Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration. J Comp Neurol 498:252-265.
59. Lin W, Popko B. 2009. Endoplasmic reticulum stress in disorders of myelinating cells. Nat Neurosci 12:379-385.
60. Madduri S, Gander B. 2010. Schwann cell delivery of neurotrophic factors for peripheral nerve regeneration. J Peripher Nerv Syst 15:93-103.
61. Marin-Husstege M, He Y, Li J, Kondo T, Sablitzky F, Casaccia-Bonnefil P. 2006. Multiple roles of Id4 in developmental myelination: Predicted outcomes and unexpected findings. Glia 54:285-296.
62. Martini R. 2001. The effect of myelinating Schwann cells on axons. Muscle Nerve 24:456-466.
63. Martini R, Fischer S, Lopez-Vales R, David S. 2008. Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia 56:1566-1577.
64. Martini R, Klein D, Groh J. 2013. Similarities between inherited demyelinating neuropathies and Wallerian degeneration: An old repair program may cause myelin and axon perturbation under nonlesion conditions. Am J Pathol 183:655-660.
65. Martini R, Mohajeri MH, Kasper S, Giese KP, Schachner M. 1995a. Mice doubly deficient in the genes for P0 and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerve myelin. J Neurosci 15:4488-4495.
66. Martini R, Schachner M. 1997. Molecular bases of myelin formation as revealed by investigations on mice deficient in glial cell surface molecules. Glia 19:298-310.
67. Martini R, Zielasek J, Toyka KV, Giese KP, Schachner M. 1995b. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat Genet 11:281-286.
68. Maurel P, Einheber S, Galinska J, Thaker P, Lam I, Rubin MB, Scherer SS, Murakami Y, Gutmann DH, Salzer JL. 2007. Nectin-like proteins mediate axon Schwann cell interactions along the internode and are essential for myelination. J Cell Biol 178:861-874.
69. Mayer JA, Larsen EC, Kondo Y, Duncan ID. 2011. Characterization of a PLP-overexpressing transgenic rat, a model for the connatal form of Pelizaeus-Merzbacher disease. Neurobiol Dis 44:231-238.
70. Meyer zu Horste G, Miesbach TA, Muller JI, Fledrich R, Stassart RM, Kieseier BC, Coleman MP, Sereda MW. 2011. The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration. Neurobiol Dis 42:1-8.
71. Mobius W, Cooper B, Kaufmann WA, Imig C, Ruhwedel T, Snaidero N, Saab AS, Varoqueaux F. 2010. Electron microscopy of the mouse central nervous system. Methods Cell Biol 96:475-512.
72. Möbius W, Patzig J, Nave KA, Werner HB. 2008. Phylogeny of proteolipid proteins: Divergence, constraints, and the evolution of novel functions in myelination and neuroprotection. Neuron Glia Biol 4:111-127.
73. Monk KR, Feltri ML, Taveggia C. 2015. New insights on schwann cell development. Glia 63:1376-1393.
74. Montag D, Giese KP, Bartsch U, Martini R, Lang Y, Bluthmann H, Karthigasan J, Kirschner DA, Wintergerst ES, Nave KA, Zielasek J, Toyka KV, Lipp HP, Schachner M. 1994. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 13:229-246.
75. Muller M, Berghoff M, Kobsar I, Kiefer R, Martini R. 2007. Macrophage colony stimulating factor is a crucial factor for the intrinsic macrophage response in mice heterozygously deficient for the myelin protein P0. Exp Neurol 203:55-62.
76. Musse AA, Gao W, Homchaudhuri L, Boggs JM, Harauz G. 2008. Myelin basic protein as a "PI(4, 5)P2-modulin": A new biological function for a major central nervous system protein. Biochemistry 47:10372-10382.
77. Nave KA, Salzer JL. 2006. Axonal regulation of myelination by neuregulin 1. Curr Opin Neurobiol 16:492-500.
78. Nave KA, Werner HB. 2014. Myelination of the nervous system: Mechanisms and functions. Annu Rev Cell Dev Biol 30:503-533.
79. Nawaz S, Kippert A, Saab AS, Werner HB, Lang T, Nave KA, Simons M. 2009. Phosphatidylinositol 4, 5-bisphosphate-dependent interaction of myelin basic protein with the plasma membrane in oligodendroglial cells and its rapid perturbation by elevated calcium. J Neurosci 29:4794-4807.
80. Nawaz S, Schweitzer J, Jahn O, Werner HB. 2013. Molecular evolution of myelin basic protein, an abundant structural myelin component. Glia 61:1364-1377.
81. Nguyen T, Mehta NR, Conant K, Kim KJ, Jones M, Calabresi PA, Melli G, Hoke A, Schnaar RL, Ming GL, Song H, Keswani SC, Griffin JW. 2009. Axonal protective effects of the myelin-associated glycoprotein. J Neurosci 29:630-637.
82. Patzig J, Jahn O, Tenzer S, Wichert SP, de Monasterio-Schrader P, Rosfa S, Kuharev J, Yan K, Bormuth I, Bremer J, Aguzzi A, Orfaniotou F, Hesse D, Schwab MH, Möbius W, Nave KA, Werner HB. 2011. Quantitative and integrative proteome analysis of peripheral nerve myelin identifies novel myelin proteins and candidate neuropathy loci. J Neurosci 31:16369-16386.
83. Patzko A, Shy ME. 2011. Update on Charcot-Marie-Tooth disease. Curr Neurol Neurosci Rep 11:78-88.
84. Peirano RI, Goerich DE, Riethmacher D, Wegner M. 2000. Protein zero gene expression is regulated by the glial transcription factor Sox10. Mol Cell Biol 20:3198-3209.
85. Pennuto M, Tinelli E, Malaguti M, Del Carro U, D'Antonio M, Ron D, Quattrini A, Feltri ML, Wrabetz L. 2008. Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice. Neuron 57:393-405.
86. Perry VH, Brown MC, Gordon S. 1987. The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration. J Exp Med 165:1218-1223.
87. Petit B, Giraudet F, Bechon C, Bardin L, Avan P, Boespflug-Tanguy O, Begou M. 2014. Mice with a deletion of the major central myelin protein exhibit hypersensitivity to noxious thermal stimuli: Involvement of central sensitization. Neurobiol Dis 65:55-68.
88. Previtali SC, Quattrini A, Fasolini M, Panzeri MC, Villa A, Filbin MT, Li W, Chiu SY, Messing A, Wrabetz L, Feltri ML. 2000. Epitope-tagged P(0) glycoprotein causes Charcot-Marie-Tooth-like neuropathy in transgenic mice. J Cell Biol 151:1035-1046.
89. Prukop T, Epplen DB, Nientiedt T, Wichert SP, Fledrich R, Stassart RM, Rossner MJ, Edgar JM, Werner HB, Nave KA, Sereda MW. 2014. Progesterone antagonist therapy in a pelizaeus-merzbacher mouse model. Am J Hum Genet 94:533-546.
90. Quintes S, Goebbels S, Saher G, Schwab MH, Nave KA. 2010. Neuron-glia signaling and the protection of axon function by Schwann cells. J Peripher Nerv Syst 15:10-16.
91. Readhead C, Schneider A, Griffiths I, Nave KA. 1994. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12:583-595.
92. Runker AE, Kobsar I, Fink T, Loers G, Tilling T, Putthoff P, Wessig C, Martini R, Schachner M. 2004. Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder. J Cell Biol 165:565-573.
93. Salzer JL, Brophy PJ, Peles E. 2008. Molecular domains of myelinated axons in the peripheral nervous system. Glia 56:1532-1540.
94. Samsam M, Mi W, Wessig C, Zielasek J, Toyka KV, Coleman MP, Martini R. 2003. The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy. J Neurosci 23:2833-2839.
95. Sanmaneechai O, Feely S, Scherer SS, Herrmann DN, Burns J, Muntoni F, Li J, Siskind CE, Day JW, Laura M, Sumner CJ, Lloyd TE, Ramchandren S, Shy RR, Grider T, Bacon C, Finkel RS, Yum SW, Moroni I, Piscosquito G, Pareyson D, Reilly MM, Shy ME. 2015. Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene. Brain. pii: awv241. [Epub ahead of print] doi: 10.1093/brain/awv241. PMID:26310628.
96. Saporta MA, Shy BR, Patzko A, Bai Y, Pennuto M, Ferri C, Tinelli E, Saveri P, Kirschner D, Crowther M, Southwood C, Wu X, Gow A, Feltri ML, Wrabetz L, Shy ME. 2012. MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B. Brain 135:2032-2047.
97. Saugier-Veber P, Munnich A, Bonneau D, Rozet JM, Le Merrer M, Gil R, Boespflug-Tanguy O. 1994. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet 6:257-262.
98. Schaeren-Wiemers N, Bonnet A, Erb M, Erne B, Bartsch U, Kern F, Mantei N, Sherman D, Suter U. 2004. The raft-associated protein MAL is required for maintenance of proper axon-glia interactions in the central nervous system. J Cell Biol 166:731-742.
99. Scherer SS, Wrabetz L. 2008. Molecular mechanisms of inherited demyelinating neuropathies. Glia 56:1578-1589.
100. Schmid CD, Stienekemeier M, Oehen S, Bootz F, Zielasek J, Gold R, Toyka KV, Schachner M, Martini R. 2000. Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance. J Neurosci 20:729-735.
101. Shy ME. 2006. Peripheral neuropathies caused by mutations in the myelin protein zero. J Neurol Sci 242:55-66.
102. Shy ME, Hobson G, Jain M, Boespflug-Tanguy O, Garbern J, Sperle K, Li W, Gow A, Rodriguez D, Bertini E, Mancias P, Krajewski K, Lewis R, Kamholz J. 2003. Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy. Ann Neurol 53:354-365.
103. Sima AA, Pierson CR, Woltjer RL, Hobson GM, Golden JA, Kupsky WJ, Schauer GM, Bird TD, Skoff RP, Garbern JY. 2009. Neuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1. Acta Neuropathol 118:531-539.
104. Skoff RP, Bessert DA, Cerghet M, Franklin MJ, Rout UK, Nave KA, Carlock L, Ghandour MS, Armant DR. 2004a. The myelin proteolipid protein gene modulates apoptosis in neural and non-neural tissues. Cell Death Differ 11:1247-1257.
105. Skoff RP, Saluja I, Bessert D, Yang X. 2004b. Analyses of proteolipid protein mutants show levels of proteolipid protein regulate oligodendrocyte number and cell death in vitro and in vivo. Neurochem Res 29:2095-2103.
106. Spiegel I, Adamsky K, Eshed Y, Milo R, Sabanay H, Sarig-Nadir O, Horresh I, Scherer SS, Rasband MN, Peles E. 2007. A central role for Necl4 (SynCAM4) in Schwann cell-axon interaction and myelination. Nat Neurosci 10:861-869.
107. Sporkel O, Uschkureit T, Bussow H, Stoffel W. 2002. Oligodendrocytes expressing exclusively the DM20 isoform of the proteolipid protein gene: Myelination and development. Glia 37:19-30.
108. Stecca B, Southwood CM, Gragerov A, Kelley KA, Friedrich VL Jr, Gow A. 2000. The evolution of lipophilin genes from invertebrates to tetrapods: DM-20 cannot replace proteolipid protein in CNS myelin. J Neurosci 20:4002-4010.
109. Stolt CC, Wegner M. 2010. SoxE function in vertebrate nervous system development. Int J Biochem Cell Biol 42:437-440.
110. Svaren J, Meijer D. 2008. The molecular machinery of myelin gene transcription in Schwann cells. Glia 56:1541-1551.
111. Tanaka H, Ma J, Tanaka KF, Takao K, Komada M, Tanda K, Suzuki A, Ishibashi T, Baba H, Isa T, Shigemoto R, Ono K, Miyakawa T, Ikenaka K. 2009. Mice with altered myelin proteolipid protein gene expression display cognitive deficits accompanied by abnormal neuron-glia interactions and decreased conduction velocities. J Neurosci 29:8363-8371.
112. Tatar CL, Appikatla S, Bessert DA, Paintlia AS, Singh I, Skoff RP. 2010. Increased Plp1 gene expression leads to massive microglial cell activation and inflammation throughout the brain. ASN Neuro 2:e00043.
113. Taveggia C, Feltri ML, Wrabetz L. 2010. Signals to promote myelin formation and repair. Nat Rev Neurol 6:276-287.
114. Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi AB, Seitanidou T, Babinet C, Charnay P. 1994. Krox-20 controls myelination in the peripheral nervous system. Nature 371:796-799.
115. Tzvetanova ID, Nave KA. 2014. Axons hooked to Schwann cell metabolism. Nat Neurosci 17:1293-1295.
116. Vaurs-Barriere C, Wong K, Weibel TD, Abu-Asab M, Weiss MD, Kaneski CR, Mixon TH, Bonavita S, Creveaux I, Heiss JD, Tsokos M, Goldin E, Quarles RH, Boespflug-Tanguy O, Schiffmann R. 2003. Insertion of mutant proteolipid protein results in missorting of myelin proteins. Ann Neurol 54:769-780.
117. Vavlitou N, Sargiannidou I, Markoullis K, Kyriacou K, Scherer SS, Kleopa KA. 2010. Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy. J Neuropathol Exp Neurol 69:945-958.
118. Viader A, Sasaki Y, Kim S, Strickland A, Workman CS, Yang K, Gross RW, Milbrandt J. 2013. Aberrant Schwann cell lipid metabolism linked to mitochondrial deficits leads to axon degeneration and neuropathy. Neuron 77:886-898.
119. Waehneldt TV. 1990. Phylogeny of myelin proteins. Ann N Y Acad Sci 605:15-28.
120. Werner H, Jung M, Klugmann M, Sereda M, Griffiths IR, Nave KA. 1998. Mouse models of myelin diseases. Brain Pathol 8:771-793.
121. Werner HB, Kramer-Albers EM, Strenzke N, Saher G, Tenzer S, Ohno-Iwashita Y, De Monasterio-Schrader P, Mobius W, Moser T, Griffiths IR, Nave KA. 2013. A critical role for the cholesterol-associated proteolipids PLP and M6B in myelination of the central nervous system. Glia 61:567-586.
122. Werner HB, Kuhlmann K, Shen S, Uecker M, Schardt A, Dimova K, Orfaniotou F, Dhaunchak A, Brinkmann BG, Mobius W, Guarente L, Casaccia-Bonnefil P, Jahn O, Nave KA. 2007. Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J Neurosci 27:7717-7730.
123. Wrabetz L, D'Antonio M, Pennuto M, Dati G, Tinelli E, Fratta P, Previtali S, Imperiale D, Zielasek J, Toyka K, Avila RL, Kirschner DA, Messing A, Feltri ML, Quattrini A. 2006. Different intracellular pathomechanisms produce diverse myelin protein zero neuropathies in transgenic mice. J Neurosci 26:2358-2368.
124. Wrabetz L, Feltri ML, Quattrini A, Imperiale D, Previtali S, D'Antonio M, Martini R, Yin X, Trapp BD, Zhou L, Chiu SY, Messing A. 2000. P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. J Cell Biol 148:1021-1034.
125. Xu W, Manichella D, Jiang H, Vallat JM, Lilien J, Baron P, Scarlato G, Kamholz J, Shy ME. 2000. Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis. J Neurosci Res 60:714-724.
126. Yin X, Baek RC, Kirschner DA, Peterson A, Fujii Y, Nave KA, Macklin WB, Trapp BD. 2006. Evolution of a neuroprotective function of central nervous system myelin. J Cell Biol 172:469-478.
127. Yin X, Crawford TO, Griffin JW, Tu P, Lee VM, Li C, Roder J, Trapp BD. 1998. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci 18:1953-1962.
128. Yin X, Kidd GJ, Wrabetz L, Feltri ML, Messing A, Trapp BD. 2000. Schwann cell myelination requires timely and precise targeting of P(0) protein. J Cell Biol 148:1009-1020.
129. Yin X, Kiryu-Seo S, Kidd GJ, Feltri ML, Wrabetz L, Trapp BD. 2015. Proteolipid protein cannot replace P0 protein as the major structural protein of peripheral nervous system myelin. Glia 63:66-77.
130. Yool DA, Klugmann M, McLaughlin M, Vouyiouklis DA, Dimou L, Barrie JA, McCulloch MC, Nave KA, Griffiths IR. 2001. Myelin proteolipid proteins promote the interaction of oligodendrocytes and axons. J Neurosci Res 63:151-164.
131. Yoshida M, Colman DR. 1996. Parallel evolution and coexpression of the proteolipid proteins and protein zero in vertebrate myelin. Neuron 16:1115-1126.